American National Bank Neurocrine Biosciences Inc Transaction History
American National Bank
- $857 Million
- Q1 2025
A detailed history of American National Bank transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, American National Bank holds 51 shares of NBIX stock, worth $6,148. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51
Previous 379
86.54%
Holding current value
$6,148
Previous $51,000
90.2%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
650Shares Held
97.2MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.71 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.2 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$667 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$586 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$322 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.5B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...